drugset / Trial / NCT02245438
Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
Study to characterize the effects of two dose combinations of Tipranavir (TPV)/Ritonavir (RTV) (TPV 750 mg/RTV 200 mg and TPV 500 mg/RTV 100 mg), administered twice-daily, on the pharmacokinetics of Norethindrone-Ethinyl Estradiol (NET/EE) 1 mg/ 0.035 mg administered as a single dose.
Timeline
- Start
- 2002-05
- Primary completion
- 2002-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norethindrone-Ethinyl Estradiol | Unknown | 0.035 mg | — |
| Subject | Norethindrone-Ethinyl Estradiol | Unknown | 1 mg | — |
| Subject | Ritonavir | Other / unclassified | 100 mg | — |
| Subject | Ritonavir | Other / unclassified | 200 mg | — |
| Subject | Tipranavir | Small molecule | 500 mg | — |
| Subject | Tipranavir | Small molecule | 750 mg | — |
Indications
No indication recorded.